Helicobacter pylori infection in patients with metabolic syndrome, with or without nonalcoholic fatty liver disease
Tóm tắt
Helicobacter pylori (HP) infection is considered a risk factor of GIT diseases, e.g., gastric and duodenal ulcers and gastric carcinomas. It is transmitted through feco/oral route and can be diagnosed by many methods, e.g., stool antigen test (SAT). Metabolic syndrome (MET S) is considered a circle of metabolic derangements that can cause some complications as ischemic changes and heart diseases. Metabolic syndrome may also cause nonalcoholic fatty liver disease (NAFLD) resulting in liver fibrosis, cirrhosis, and HCC. The study included 300 subjects recruited from Obesity Clinic and Diabetes & Endocrinology Unit, Specialized Medical Hospital, Mansoura University. Two hundred of metabolic syndrome patients were subdivided into two groups according to the presence or absence of NAFLD, in addition to 100 subjects not having metabolic syndrome and served as control group. We found that HP infection is more frequent in MET S with NAFLD patients (73%) than in MET S without NAFLD (47%) with (P value < 0.001) emphasizing that HP infection increases the risk of NAFLD development in patients with MET S. The study proved that HP infection is associated with increased degree of fibrosis significantly (P value < 0.001) with progression to marked fibrosis which may complicate with NASH with over all predictive value of 75% especially in patients with hyperglycemia. Our findings show that a circle of metabolic abnormalities seems to be attributed to HP infection in MET S patients increasing the risk of fatty liver and progression to marked fibrosis especially with coexistent hyperglycemia, dyslipidemia, and upper body obesity. Diagnosis and early eradication of HP infection will help in decreasing metabolic disturbances and possibility of NAFLD, and protect against marked fibrosis progression.
Tài liệu tham khảo
Eslick GD, Lim LL, Byles JE, Xia HH, Talley NJ (1999) Association of Helicobacter pylori infection with gastric carcinoma: a meta-analysis. Am J Gastroenterol 94(9):2373–2379. https://doi.org/10.1111/j.1572-0241.1999.01360.x
Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7-14 June 1994. (1994). IARC monographs on the evaluation of carcinogenic risks to humans. World Health Organization, International Agency for Research on Cancer, 61, 1–241. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/7715068
Sonnenberg A, Genta RM (2013) Helicobacter pylori is a risk factor for colonic neoplasms. Am J Gastroenterol 108(2):208–215. https://doi.org/10.1038/ajg.2012.407
Alberti KGMM, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart J-C, James WPT, Loria CM, Smith SC (2009) Harmonizing the metabolic syndrome. Circulation 120(16):1640–1645. https://doi.org/10.1161/circulationaha.109.192644
Radaelli MG, Martucci F, Perra S, Accornero S, Castoldi G, Lattuada G et al (2018) NAFLD/NASH in patients with type 2 diabetes and related treatment options. J Endocrinoll Investig 41(5):509–521. https://doi.org/10.1007/s40618-017-0799-3
Wong RJ, Aguilar M, Cheung R, Perumpail RB, Harrison SA, Younossi ZM, Ahmed A (2015) Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States. Gastroenterology 148(3):547–555. https://doi.org/10.1053/j.gastro.2014.11.039
Dixon JB, Bhathal PS, Hughes NR, O’Brien PE (2004) Nonalcoholic fatty liver disease: improvement in liver histological analysis with weight loss. Hepatology (Baltimore, Md.) 39(6):1647–1654. https://doi.org/10.1002/hep.20251
Cindoruk M, Cirak MY, Unal S, Karakan T, Erkan G, Engin D et al (2008) Identification of Helicobacter species by 16S rDNA PCR and sequence analysis in human liver samples from patients with various etiologies of benign liver diseases. Eur J Gastroenterol Hepatol 20(1):33–36. https://doi.org/10.1097/MEG.0b013e3282efa4f2
Pirouz T, Zounubi L, Keivani H, Rakhshani N, Hormazdi M (2009) Detection of Helicobacter pylori in paraffin-embedded specimens from patients with chronic liver diseases, using the amplification method. Dig Dis Sci 54(7):1456–1459. https://doi.org/10.1007/s10620-008-0522-5
Polyzos SA, Kountouras J, Papatheodorou A, Patsiaoura K, Katsiki E, Zafeiriadou E et al (2013) Helicobacter pylori infection in patients with nonalcoholic fatty liver disease. Metabolism 62(1):121–126. https://doi.org/10.1016/j.metabol.2012.06.007
Mendrick DL, Diehl AM, Topor LS, Dietert RR, Will Y, La Merrill MA, Bouret S, Varma V, Hastings KL, Schug TT, Emeigh Hart SG, Burleson FG (2017) Metabolic syndrome and associated diseases: from the bench to the clinic. Toxicol Sci 162(1):36–42. https://doi.org/10.1093/toxsci/kfx233D
Okushin K, Takahashi Y, Yamamichi N, Shimamoto T, Enooku K, Fujinaga H et al (2015) Helicobacter pylori infection is not associated with fatty liver disease including non-alcoholic fatty liver disease: a large-scale cross-sectional study in Japan. BMC Gastroenterol 15(1):25. https://doi.org/10.1186/s12876-015-0247-9
Eshraghian A (2014) Epidemiology of Helicobacter pylori infection among the healthy population in Iran and countries of the Eastern Mediterranean Region: a systematic review of prevalence and risk factors. World J Gastroenterol 20(46):17618–17625. https://doi.org/10.3748/wjg.v20.i46.17618
Babusik P, Bilal M, Duris I (2011) Nonalcoholic fatty liver disease of two ethnic groups in Kuwait: comparison of prevalence and risk factors. Med Princ Pract 21(1):56–62. https://doi.org/10.1159/000331591
Van Werven JR, Marsman HA, Nederveen AJ, Smits NJ, Ten Kate FJ, Van Gulik TM, Stoker J (2010) Assessment of hepatic steatosis in patients undergoing liver resection: comparison of US, CT, T1-weighted dual-echo MR imaging, and point-resolved 1H MR spectroscopy. Radiology 256(1):159–168. https://doi.org/10.1148/radiol.10091790
Angulo P, Hui JM, Marchesini G, Bugianesi E, George J, Farrell GC et al (2007) The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology 45(4):846–854. https://doi.org/10.1002/hep.21496
Leal YA, Cedillo-Rivera R, Simón JA, Velázquez JR, Flores LL, Torres J (2011) Utility of stool sample-based tests for the diagnosis of Helicobacter pylori infection in children. J Pediatr Gastroenterol Nutr 52(6):718–728. https://doi.org/10.1097/MPG.0b013e3182077d33
Burucoa C, Axon A (2017) Epidemiology of Helicobacter pylori infection. Helicobacter 22:e12403. https://doi.org/10.1111/hel.12403
de Alwis NMW, Day CP (2008) Non-alcoholic fatty liver disease: the mist gradually clears. J Hepatol 48:S104–S112. https://doi.org/10.1016/j.jhep.2008.01.009N
Bhala N, Jouness R, Bugianesi E (2013) Epidemiology and natural history of patients with NAFLD. Curr Pharm Des 19(29):5169–5176. https://doi.org/10.2174/13816128113199990336N
Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K et al (2012) The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 55(6):2005–2023. https://doi.org/10.1002/hep.25762
Chen C, Zhang C, Wang X, Zhang F, Zhang Z, Ma P, Feng S (2019) Helicobacter pylori infection may increase the severity of nonalcoholic fatty liver disease via promoting liver function damage, glycometabolism, lipid metabolism, inflammatory reaction and metabolic syndrome. Eur J Gastroenterol Hepatol. https://doi.org/10.1097/MEG.0000000000001601
Hooi JKY, Lai WY, Ng WK, Suen MMY, Underwood FE, Tanyingoh D et al (2017) Global prevalence of Helicobacter pylori infection: systematic review and meta-analysis. Gastroenterology 153(2):420–429. https://doi.org/10.1053/j.gastro.2017.04.022
Muhsen K, Athamna A, Athamna M, Spungin-Bialik A, Cohen D (2006) Prevalence and risk factors of Helicobacter pylori infection among healthy 3- to 5-year-old Israeli Arab children. Epidemiol Infect 134(5):990–996. https://doi.org/10.1017/S0950268806006030
Cover TL, Blaser MJ (2009) Helicobacter pylori in health and disease. Gastroenterology 136(6):1863–1873. https://doi.org/10.1053/j.gastro.2009.01.073
Ahmed KS & Ahmed Khan, A. (2014). Functional characterization of Mycobacterium tuberculosis DosR regulon genes view project endonucleases in H. pylori view project. Retrieved from https://www.researchgate.net/publication/7207648
Agah S, Khedmat H, Ghamar-Chehred ME, Hadi R, Aghaei A (2016) Female gender and Helicobacter pylori infection, the most important predisposition factors in a cohort of gastric cancer: a longitudinal study. Caspian J Int Med 7(2):136–141
Abdel-Razik A, Mousa N, Shabana W, Refaey M, Elhelaly R, Elzehery R et al (2018) Helicobacter pylori and non-alcoholic fatty liver disease: a new enigma? Helicobacter 23(6):e12537. https://doi.org/10.1111/hel.12537
Rasmi Y, Seyyed-Mohammadzad MH (2012) Frequency of Helicobacter pylori and cytotoxine associated gene A antibodies in patients with cardiac syndrome X. J Cardiovasc Dis Res 3(1):19–21. https://doi.org/10.4103/0975-3583.91597
Lim SH, Kim N, Kwon JW, Kim SE, Baik GH, Lee JY et al (2019) Positive association between Helicobacter pylori infection and metabolic syndrome in a Korean population: a multicenter nationwide study. Dig Dis Sci. https://doi.org/10.1007/s10620-019-05544-3
Liu M, Wang J, Zeng J, Cao X, He Y (2017) Association of NAFLD with diabetes and the impact of BMI changes: a 5-year cohort study based on 18,507 elderly. J Clin Endocrinol Metab 102(4):1309–1316. https://doi.org/10.1210/jc.2016-3440M
Friedman SL, Neuschwander-Tetri BA, Rinella M, Sanyal AJ (2018) Mechanisms of NAFLD development and therapeutic strategies. Nat Med 24:908–922. https://doi.org/10.1038/s41591-018-0104-9
Li M, Shen Z, Li YM (2013) Potential role of Helicobacter pylori infection in nonalcoholic fatty liver disease. World J Gastroenterol 19:7024–7031. https://doi.org/10.3748/wjg.v19.i41.7024
Doğan Z, Filik L, Ergül B, Sarikaya M, Akbal E (2013) Association between Helicobacter pylori and liver-to-spleen ratio. Eur J Gastroenterol Hepatol 25(1):107–110. https://doi.org/10.1097/meg.0b013e3283590c10Z